Patient|Derived Organoid Model in the Prediction of ...

Patient-Derived Organoid Model in the Prediction of ...

Patient-derived organoid xenograft model was chosen as the in vivo model in our research instead of the patient-derived xenograft model because ...

Patient-Derived Organoid Model in the Prediction of ... - PubMed

As an emerging technology in precision medicine, the patient-derived organoid (PDO) technology has been indicated to provide novel ...

Patient-derived Organoid Model for Predicting the Chemoresponse ...

However, histopathologically similar tumors originating from the same organ are treated with identical or similar chemotherapeutic regimens regardless of ...

Patient-derived organoids as a predictive biomarker for treatment ...

Effective predictive biomarkers are needed to enable personalized medicine and increase treatment efficacy and survival for cancer patients, ...

Review Patient-derived organoids in precision cancer medicine

They offer a physiologically relevant model to address important questions in cancer research. The generation of patient-derived organoids (PDOs) ...

Patient-derived organoids as a potential model to predict response ...

Selection of cancer patients for treatment with immune checkpoint inhibitors remains a challenge due to tumour heterogeneity and variable ...

Patient-derived organoids in precision cancer medicine: Med

Pre-clinical models include 2D tumor cell cultures encompassing both primary patient-derived cells (PDCs) and immortalized cell lines, mouse ...

The Efficacy of Using Patient-Derived Organoids to Predict ... - MDPI

Patient-derived tumour organoids are three-dimensional models of patients' cancer cells which can be tested for sensitivity to various treatment options in the ...

Unified framework for patient-derived, tumor-organoid-based ...

Predictive drug testing of patient-derived tumor organoids (PDTOs) holds promise for personalizing treatment of metastatic colorectal cancer ...

Patient-derived organoid (PDO) platforms to facilitate clinical ...

Based on recent advances in organoid research as well as the need to find more accurate models for drug screening in cancer research, ...

Patient-Derived Organoids Predict Chemoradiation Responses of ...

Accumulating evidence indicates that patient-derived organoids (PDOs) can predict drug responses in the clinic, but the ability of PDOs to ...

Patient-Derived Cancer Organoids as Predictors of Treatment ...

For the purpose of this review, cancer organoids were defined as stem-cell derived three-dimensional cell culture models derived from primary ...

Patient-Derived Tumor Organoids Can Predict the Progression-Free ...

The new patient-derived tumor organoid–based drug test model, which includes the patient-derived tumor organoid–based drug test, primary tumor location, ...

Patient-Derived Organoids in Precision Medicine: Drug Screening ...

Clinical trials have been performed using patient-derived organoids (PDO) as a tool for personalized medical decisions to predict patients' ...

Patient-derived organoids model treatment response of metastatic ...

Patient-derived organoids (PDOs) have recently emerged as robust preclinical models; however, their potential to predict clinical outcomes in ...

Patient-derived organoids in human cancer: a platform for ...

In contrast to conventional models, tumor organoids offer an intuitive, dependable, and efficient in vitro research model by conserving the ...

A Patient-Derived Organoid-Based Radiosensitivity Model for the ...

Patient-derived tumor organoids closely resemble original patient tumors. We conducted this co-clinical trial with treatment-naive rectal ...

Spatio-Temporal Analysis of Patient-Derived Organoid Videos Using ...

Abstract:Over the last ten years, Patient-Derived Organoids (PDOs) emerged as the most reliable technology to generate ex-vivo tumor avatars ...

Patient-derived organoids can predict response to chemotherapy in ...

We developed an in vitro test based on patient-derived tumor organoids (PDOs) from metastatic lesions to identify nonresponders to standard-of- ...

Patient-Derived Organoid Model in the Prediction of ...

Patient-Derived Organoid Model in the Prediction of Chemotherapeutic Drug Response in Colorectal Cancer. · Minglu Hao, Zhipeng Cao, +5 authors. Pu Chen ...